Rakuten Medical

San Diego, CA · Founded 2010 · Privately Held (backing)

Developer of precision-targeted cancer therapies designed to treat solid tumors. Rakuten Medical is based in San Diego, CA and was founded in 2010. Its last reported valuation was $818 million in Mar 2024. It has raised $887 million across 11 recorded rounds; the latest was an $112 million later-stage round in Jul 2025.

Last reported valuation
$818.0M
Oct 2026
Priced at
—
Total raised
$887.1M
Last round
Later Stage VC
Jul 2025

Rakuten Medical key facts

as of Oct 2026
  • Developer of precision-targeted cancer therapies designed to treat solid tumors.
  • Rakuten Medical is valued at approximately $818.0M as of Oct 2026 (last reported valuation).
  • It has raised $887.1M across 11 recorded rounds; the latest was Later Stage VC ($111.5M) in Jul 2025.
  • Notable investors include General Catalyst, Mizuho Bank, Rakuten Capital, ABC Partners, Abies Capital — 19 tracked in total.
  • Rakuten Medical has filed 12 Form Ds with the SEC since 2019, most recently May 2025 ($1.9M sold to 14 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$818.0M

Rakuten Medical's last reported valuation, Mar 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Rakuten Medical with a free account
  • ·The complete investor list: 19 names
  • ·Watch Rakuten Medical: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Rakuten Medical funding rounds

11 rounds
Jul 2025Later Stage VC$111.5MSEC filing▮
Dec 2024Seed Round$1.9MSEC filing▮
Mar 2024Seed Round$4.2MSEC filing▮
Aug 2023Later Stage VC$104.8MSEC filing▮
Dec 2022Debt$70.0MSEC filing▮

Rakuten Medical valuation

Rakuten Medical's last reported valuation was $818 million in Mar 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Rakuten Medical raised?

Rakuten Medical has raised $887 million across 11 recorded rounds since 2019. The largest was a $100 million later-stage round in Jul 2019; the most recent was an $112 million later-stage round in Jul 2025.

Rakuten Medical has filed 12 Form Ds with the SEC since 2019, most recently in May 2025 ($1.9 million sold to 14 investors).

Rakuten Medical investors

19 investors are on record for Rakuten Medical, including General Catalyst, Mizuho Bank, Rakuten Capital and ABC Partners. The later-stage round in Jul 2025 drew 26 investors.

About Rakuten Medical

Developer of precision-targeted cancer therapies designed to treat solid tumors. The company's therapies consist of a cancer-targeting monoclonal antibody conjugated to a photoactivatable molecule to gain anticancer activity upon light-mediated activation at the tumor site, enabling patients with recurrent head and neck cancer to access oncologic drugs that permit rapid cancer cell killing without damage to the surrounding healthy tissues.

Sector
Healthcare
HQ
San Diego, CA, United States
Founded
2010
Employees
126
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.